Research Topics
Species | Suzanne BakerSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Inducible Cre recombinase activity in mouse mature astrocytes and adult neural precursor cellsLionel M L Chow
Department of Developmental Neurobiology, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, TN, 38105, USA
Transgenic Res 17:919-28. 2008..These mouse lines will provide important tools to dissect gene function in glial cells and in gliomagenesis...
Redefining p53--entering the tumor suppressor eraSuzanne J Baker
Department of Developmental Neurobiology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA
Cell Cycle 2:7-8. 2003
PTEN and the PI3-kinase pathway in cancerNader Chalhoub
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Annu Rev Pathol 4:127-50. 2009..The significance and complexity of PI3K signaling make it an important but challenging therapeutic target for cancer...
PTEN enters the nuclear ageSuzanne J Baker
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cell 128:25-8. 2007..2007) and Trotman et al. (2007) describe how ubiquitination regulates PTEN stability and its nuclear localization. Additionally, Shen et al. (2007) report that a nuclear pool of PTEN helps to maintain chromosomal stability...
Tumour-suppressor function in the nervous systemSuzanne J Baker
Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN 38105, USA
Nat Rev Cancer 4:184-96. 2004
Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine gliomaAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA
Cancer 116:4632-7. 2010..A prospective, multicenter study was conducted to assess the feasibility of tissue collection at autopsy and its suitability for molecular analyses in children with diffuse intrinsic pontine glioma...
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade gliomaAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Mail Stop 260, 262 Danny Thomas Place, Memphis, TN 38105, USA
Clin Cancer Res 15:701-7. 2009....
Clinical and molecular characteristics of malignant transformation of low-grade glioma in childrenAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 25:682-9. 2007..To analyze the clinical and molecular characteristics of malignant transformation (MT) of low-grade glioma (LGG) in children...
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivoChang Hyuk Kwon
Department of Developmental Neurobiology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA
Proc Natl Acad Sci U S A 100:12923-8. 2003..mTOR inhibitors may be useful therapeutic agents for diseases in brain resulting from PTEN deficiency such as Lhermitte-Duclos disease or glioblastoma multiforme...
PTEN function in normal and neoplastic growthLionel M L Chow
Department of Developmental Neurobiology, St Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA
Cancer Lett 241:184-96. 2006..Elucidation of the mechanisms regulating activation of unique downstream effectors that mediate distinct outcomes of PTEN loss will augment our understanding of tumorigenesis and ultimately lead to novel therapeutic options...
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 28:3061-8. 2010..To define copy number alterations and gene expression signatures underlying pediatric high-grade glioma (HGG)...
Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brainsNader Chalhoub
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Genes Dev 23:1619-24. 2009..Our results show Pdk1-dependent and Pdk1-independent abnormalities in Pten-deficient brains, and demonstrate cell type specific differences in feedback regulation of the ubiquitous PI3K pathway...
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine gliomaBarbara S Paugh
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 29:3999-4006. 2011..We evaluated a large cohort of DIPGs to identify recurrent genomic abnormalities and gene expression signatures underlying DIPG...
Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cellsJoby J Westmoreland
Department of Genetics and Tumor Cell Biology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Dev Biol 334:285-98. 2009....
Inducible Cre recombinase activity in mouse cerebellar granule cell precursors and inner ear hair cellsLionel M L Chow
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Dev Dyn 235:2991-8. 2006..This mouse line provides a powerful tool to dissect gene function at early and late stages in development of the cerebellum and inner ear...
S6k1 is not required for Pten-deficient neuronal hypertrophyNader Chalhoub
Department of Developmental Neurobiology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA
Brain Res 1100:32-41. 2006..Thus, we conclude that S6k1 is not required to cause hypertrophy of Pten-deficient neurons. This study reveals a cell type-dependent role for S6k1 in PI3K-dependent hypertrophy...
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivoMelissa M Fraser
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer Res 64:7773-9. 2004..This study shows cell-type dependent effects of Pten loss in the adult brain, including increased astrocyte proliferation that may render astroglial cells susceptible to neoplastic transformation or malignant progression...
Interferon induces the interaction of prothymosin-alpha with STAT3 and results in the nuclear translocation of the complexChuan He Yang
Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis 38103, USA
Exp Cell Res 298:197-206. 2004....
The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivoTomohiro Kawaguchi
Brain Tumor Research Center, Department of Neurological Surgery, The University of California-San Francisco Comprehensive Cancer Center, CA 94115-0875, USA
Cancer Res 66:11331-40. 2006..These results show that tumstatin, previously considered to be only an endogenous inhibitor of angiogenesis, also directly inhibits the growth of tumors in a manner dependent on Akt/mTOR activation...
Research Grants
- Normal and Neoplastic Growth Regulation in the BrainSuzanne Baker; Fiscal Year: 2007..This includes characterization of the function of downstream effector genes in the cerebellum and the creation of new mutant mouse strains to investigate its contribution to growth, proliferation and tumorigenesis. ..
- Pten regulation of growth and neoplasia in the brainSuzanne Baker; Fiscal Year: 2006..We will determine if the same signaling pathways that contribute to aberrant regulation of cell size in post-mitotic neurons are critical to Pten function in normal and neoplastic growth in astrocytes. ..
- Molecular Pathogenesis of Ewing SarcomaSuzanne Baker; Fiscal Year: 2005..Finally, we will establish a mouse model to evaluate the consequences of EWS/FLI expression on tumorigenesis and development in vivo. ..
- Pten and P13K regulation of growth and neoplasia in the brainSuzanne J Baker; Fiscal Year: 2010..The proposed experiments will provide improved insights into the regulation of PI3K signaling in brain tumors that will be essential for informed design of therapeutic inhibition of this pathway in tumors with distinct mutations. ..
